Vimarsana
Biggest News Aggregation in the World

Captab Biotec News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Captab Biotec. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Captab Biotec Today - Breaking & Trending Today

Poor quality: Lens on Indian drugs - Vimarsana News

Poor quality: Lens on Indian drugs

Gambia introducing India-specific testing and controls

IPCA Labs, Cadila Healthcare among 16 Indian pharma firms blacklisted in Nepal - Vimarsana News

IPCA Labs, Cadila Healthcare among 16 Indian pharma firms blacklisted in Nepal

Kathmandu: In a major setback, Nepal has banned import of medicines from 16 Indian pharmaceutical companies including IPCA Laboratories, Cadila Healthcare, Baba Ramdev promoted Divya Pharmacy for...

Nepal bans import of medicines from 16 Indian companies, including Patanjali's Divya Pharmacy, Zydus - Vimarsana News

Nepal bans import of medicines from 16 Indian companies, including Patanjali's Divya Pharmacy, Zydus

The move comes after the WHO issued an alert on Indian-made cough syrups, which were allegedly responsible for the deaths of children in Gambia.

Ramdev's Divya Pharmacy among 16 Indian pharma companies blacklisted by Nepal - Vimarsana News

Ramdev's Divya Pharmacy among 16 Indian pharma companies blacklisted by Nepal

The Department of Drug Administration, in a notice issued on December 18 asked the local agents in Nepal, which have been supplying these medicines, to immediately recall them. Get more Companies News and Business News on Zee Business.

Source: zeebiz.com
Baba Ramdev's Divya Pharmacy among 16 Indian pharmaceutical companies banned by Nepal - Vimarsana News

Baba Ramdev's Divya Pharmacy among 16 Indian pharmaceutical companies banned by Nepal

Nepal's drug regulatory authority has blacklisted 16 Indian pharmaceutical companies, including Divya Pharmacy which manufactures Yoga Guru Ramdev's Patanjali products, stating that they failed to comply with the World Health Organisation's (WHO) drug manufacturing standards.